SMS Pharmaceuticals
SMSPHARMA · Pharma > Pharmaceuticals & Drugs · Chairman: Ramesh Babu · MD: Ramesh Babu · Listing date: Feb. 28, 2007 · Employees: 1080 · Hyderabad · http://www.smspharma.com

Stock Price vs Company Growth
1d
1.7%
1w
3.6%
1m
15.3%
3m
29.2%
6m
47.2%
1y
102.1%
5y
25.3%
10y
17.9%
all
14.5%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 430 1.7%
294
446
Company Overview

Sales
897 Cr
Growth: 15.9%
Profit after Tax
89.6 Cr
Growth: 6.2%
Small Cap
4,031 Cr
P/E: 42.1x
Industry P/E: 28.0x
Fundamentals

Sales (Cr) ₹ 897
Growth 15.9%
EBITDA 19.2%
P/S 4.5x
Dividend 0.1%
P/E 42.1x
Book Value ₹ 75.8
PEG Ratio 2.6x
ROE 13.3%
P/B 5.6x
Shareholding Pattern

Institutions
Venkata Subbaraju Penmatsa .
2.13 %
Vivek Mundra
1.23 %
Aniruddh Mundra
1.13 %
Madhusudan Murlidhar Kela
1.1 %
Iepf
0.07 %
Promoters
Ramesh Babu Potluri
18.37 %
Hima Bindu Potluri
17.47 %
Vamsi Krishna Potluri
15.74 %
Potluri Infra Projects Llp
8.68 %
Trilok Potluri
2.58 %
Others
Increase    Decrease    No change
Company Profile Detailed

SMS Pharmaceuticals Ltd. is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. What started off as a single facility single product manufacturing company in 1990 grew to be a multi location group having product list spreading across an array of therapeutic segments. SMS is currently a listed company having ever appreciating international and domestic customer base.
Investors (45)
Followers (1)